Skip to main content

Table 5 A summary of the dosimetric parameters for \(\mathbb {P}^{\text {WH}}\), \(\mathbb {P}^{\text {WF}}\) and \(\mathbb {P}^{\text {RF}}\) plans for a single patient

From: Radiomics based targeted radiotherapy planning (Rad-TRaP): a computational framework for prostate cancer treatment planning with MRI

Parameter

Whole gland homogeneous (\(\mathbb {P}^{\text {WH}}\))

Whole gland with focal boost (\(\mathbb {P}^{\text {WF}}\))

Focal (\(\mathbb {P}^{\text {RF}}\))

(\(\mathbb {P}^{\text {WF}}- \mathbb {P}^{\text {WH}}\))

(\(\mathbb {P}^{\text {RF}}-\mathbb {P}^{\text {WH}}\))

Prostate

V 100 %

99.6

99.32

94.21

-0.28

-5.39

D 98 Gy.

80.2

79.6

85.2

-0.6

5

D min (0.03 cc.) Gy.

76.7

78.5

83.8

1.8

7.1

D max (0.03 cc.) Gy.

81.9

102.5

91.3

20.6

9.4

Mean Dose Gy.

80.8

84.09

87.9

3.29

7.1

Bladder

V 15% Gy.

60.7

65.5

1.45

4.8

-59.25

V 25% Gy.

46.9

51.7

1.85

4.8

-45.05

V 35% Gy.

36.1

42.6

1.67

6.5

-34.43

V 50% Gy.

24.1

33

1.45

8.9

-22.65

Rectum

V 15% Gy.

63.7

60

10.5

-3.7

-53.2

V 25% Gy.

50.8

50.2

4.35

-0.6

-46.45

V 35% Gy.

36.5

42.8

2.65

6.3

-33.85

V 50% Gy.

23.2

27

1.9

3.8

-21.3

Penile bulb

Mean Dose Gy.

48.98

61.97

3.65

12.99

-45.33

L. Femoral Head

Mean Dose Gy.

22.1

23.3

2.3

1.2

-19.8

R. Femoral Head

Mean Dose Gy.

19.8

21.3

1.4

1.5

-18.4

  1. It can be observed that the \(\mathbb {P}^{\text {RF}}\) resulted in significant reduction in the dosage to surrounding regions including bladder, rectum, penile bulb and the femoral heads (highlighted in bold-face)